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Introduction. Medical treatment in chronic constipation is not always successful. Surgery is indicated in unresponsive selected
severe cases. This study presents the distal venous colic ligation in rat as a novel surgical approach. Materials and Methods.1 6r a t s
(studygroup)wereevaluatedin3phasesof6dayseach:A(normalconditions),B(loperamide-inducedconstipation),andC(colic
vein legation) and compared with rats treated in phase C with PEG 4,000 (control group). Blood biochemical and physiological
parameters, daily fecal water content (FWC), and histological analysis were performed in all study phases. Results. No biochemical
and physiological parameters changes were observed. FWC decreased in phase B and increased in phase C in both groups with a
grow up to 2.3-fold in study group compared to control (P<0.0001). Moreover, in study group, a high number of colonic goblet
c e l l sw e r ed e t e c t e d( p h a s eCv e r s u sp h a s eB :P<0.001) while no diﬀerences were registered in control. Conclusion. By ligature of




A consensus deﬁnition of constipation was reached in the
ROME conference held in 1992 with a further revision
in 2001 [1]. Two or more of the following symptoms,
presentintheprevious3months,wereconsidereddiagnostic
for constipation: symptom onset at least 6 months before
diagnosis;strainingduringatleast25%ofdefecations;lumpy
or hard stools in at least 25% of defecations; sensation
of incomplete evacuation for at least 25% of defecations;
sensation of anorectal obstruction/blockage for at least 25%
of defecations; manual maneuvers to facilitate at least 25% of
defecations; fewer than 3 defecations/week [1].
For its high prevalence constipation represents also
an extensive economical burden in terms of general and
specialistical medical care due to diagnostic procedures,
hospitalization, and therapy [2, 3]. The pathogenesis of
chronic constipation is often unclear; in only about 10%
of cases some metabolic or structural etiological conditions
are identiﬁed [4]. Generally, each patient’s complaint is
diﬀerent, making it diﬃcult to understand the problem
and ﬁnd appropriate therapeutic measures. Lifestyle changes
are not often successful, and diﬀerent types of laxatives
are usually necessary. Pharmacological treatment is the ﬁrst
therapeutical choice for constipation and surgery is only
reserved as the last option when conservative treatments
have failed, and therefore it should be limited to refractory
constipation, in most cases due to mixed conditions [1].
Colonresection,inparticular,seemstohavebeneﬁcialeﬀects
in some cases of inertia coli [5]. Although the great eﬀort in
identifying the best treatment options for patients aﬀected
by chronic constipation, the results are often still partial and
unsatisfactory [1–6].
In the attempt to address this issue we took inspiration
from our direct clinical experience [7]. In that occasion
we treated a 25-year-old women with acute liver failure for
intoxication from tetracycline, through the arterialization of
the portal vein. In particular, with the aim to increase the2 Journal of Biomedicine and Biotechnology
oxygenation of the blood coming to the liver through the
portal system, a branch of the inferior mesenteric artery
was connected to the inferior mesenteric vein. At long-
term follow-up, the patient referred a reversal of the chronic
constipation that she had always experienced before. We
hypothesized that the physiopathological mechanism for
the resolution of constipation was that the ligation of the
inferior mesenteric vein, performed to allow the anastomosis
between the arterial and the venous splanchnic system,
by impairing the colic vein drainage, must decrease the
reabsorption of the luminal solute and water, increasing the
colonic water content.
Loperamide is a synthetic opioid agonist, able to induce a
constipation in animal model by extension of the evacuation
time [8], inhibition of colonic peristalsis [9], and reduction
of colonic mucus [10]. In order to better characterize the
correlationbetweencolicveincongestionandimprovedfecal
transit, the aim of this study was to evaluate the eﬀect
of the colic vein ligature in rat with loperamide-induced
constipation.
2.MaterialsandMethods
2.1. Animals and Constipation Induction. In our study we
used 25 male Sprague-Dawley rats (Charles River Labo-
ratories, Calco, Italy) weighing about 400g/b.w.: 16 rats
were enrolled in study group and 9 in control group. All
animal procedures were approved by the local committee
for care and use of laboratory animals of the University of
Bologna and performed according to Italian governmental
and international guidelines on animal experimentation.
Constipation in rats was induced by injection of loperamide
(Sigma-Aldrich) at the dose of 0.15mg/100g twice a day
subcutaneously.
2.2. Study Design. T h ea n i m a l sw e r es u b j e c t e dt oat h r e e
study phases. The ﬁrst phase (A; from day 1 to 6) was the
controlperiod, usefulto collectthe basal physical parameters
of each animal. The second phase (B; from day 6 to 12)
was the period of loperamide-induced constipation. In the
thirdphase (C; fromday 12to18) loperamide wascontinued
and animals of study group underwent colic vein ligation
(Figure 1),whileanimalsofcontrolgroupwereadministered
PEG 4,000 (Sigma-Aldrich) (250mg/kg/day). The equivalent
dose for the drug to be administered to rat could not be
calculated by the usual formula corrected for the ratio of
human serum albumin Kg/rat serum albumin Kg [11], due
to the very poor intestinal absorption of PEG 4,000 (from
0.05 and 2.5%). Since this formula cannot apply to drugs
with little or no intestinal absorption, we chose a dose which
was 50% of the minimal dose inducing toxic eﬀects, such
as severe diarrhoea and tremor, obtained by the previous
evaluationoftheclinicaleﬀectofthedruginadose-response
curve from 100mg/kg/day to 1000mg/kg/day in a cohort of
healthy rats (data non reported). To perform a histological
comparative analysis of the colic mucosa in the diﬀerent
study phases, 4 of the 16 animals used were sacriﬁced at
the end of phase A, 4 at the end of phase B, and 8 at the
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Figure 1: Study group design.
similarly sacriﬁced at the end of each phase. Biochemical,
physiological, and histological parameters of the animals
were evaluated through the three sequential phases, for a
total of 18 days.
2.3. Biochemical and Physiological Parameters. We assessed
serum osmolarity and concentration of proteins, sodium,
and chloride. The analysis was performed at the end of the
three study phases (A, B, and C).
Thephysiologicalparametersdailyevaluatedinourstudy
were body weight, food and water intake, urine volume,
weight of wet, and dry fecal pellets. These parameters
were collected every morning at the same time in order
to minimize the physiological variables. The procedure
of feces drying was performed with UNIVAPOR vacuum
concentrator. The fecal samples were let to dry for 24 hours
at room temperature obtaining a complete removal of water
and other volatile substances. The water content of the fecal
pellet was calculated as the diﬀerence between the wet and
dry weights of the pellet.
2.4. Histology. The colic mucosa of all the animals was
examined using periodic acid-Shiﬀ (PAS) staining to detect
the presence of the intracellular mucus, identifying the
number of goblet cells. For this experiment a standard
PAS staining protocol was adopted; after deparaﬃnization
and hydratation to water, the slides were oxidized in 0.5%
periodic acid solution for 5 minutes, then rinsed in distilled
water and placed in Schiﬀ reagent for 15 minutes. Afterwards
the slides were washed under tap water for 5 minutes and
then counterstained in Mayer’s hematoxylin for 1 minute
before the dehydration and the placement of the mounting
medium and coverslip. The slides were then analyzed under
an optical microscope, and the number of PAS positive cells
in the crypts of colic epithelium among the diﬀerent groups
was counted: three ﬁelds per slide at a magniﬁcation of 20X,
three slides per animal.
2.5. Surgical Procedure. The animals were anesthetized
through intraperitoneal injection of xylazine-tiletamine-
zolazepam (Zoletil, Virbac) at the dose of 0.1mL/100g.
A median xipho-pubic incision was performed in order
to expose the abdominal organs and the intestinal vessels.
The colic vein was identiﬁed at the inferior edge of the
pancreas and ligated and cut under microscope visualization
(Figure 2). After the procedure an immediate colic venous
congestion was observed below the ligation. The abdominal
wall was then closed in two layers.Journal of Biomedicine and Biotechnology 3
Figure 2: Ligation and cut of the colic vein.
3. Results
3.1. Biochemical and Physiological Parameters
Study Group. No signiﬁcant diﬀerences of the biochemical
parameters evaluated were detected at the end of each of
the three phases of the study. Concerning physiological
parameters, the body weight was substantially unchanged
during the three phases of the study: 424 ± 12, 432 ± 10,
403 ± 7g/b.w. respectively for phases A, B, and C. Food
and water intake remained constant in each phase; the mean
daily food intake value was 20.2, 23, and 19.6g, respectively,
in phase A, B, and C. The volume of urine produced was
unchanged during phase A and B with a mean of 13mL
±1 and increased slightly to 15mL ±1 during phase C. The
weight of total daily fecal production also remained constant
around 7.5g/day.
Concerning fecal water content, the mean water content
in the feces decreased from 49.4 ± 0.7% (phase A) to 47.1 ±
0.8% after induction of constipation with loperamide (phase
B). After the surgical procedure the water content of the
feces increased to 51.4 ± 1%, that was signiﬁcantly higher
compared to the constipated rats (phase C versus phase B;
P<0.0001). A similar trend was observed concerning the
watercontentof thesingle fecalpellet, thatwasreduced from
59.7±0.8% (phaseA)to55.0±0.7% (phaseB)andincreased
a f t e rt h ec o l i cv e i nl i g a t i o nt o6 2 .6 ± 0.9% (phase C versus
phase B: P<0.0001).
Control Group. No signiﬁcant diﬀerences were found at
the end of each period in the biochemical parameters. As
for the physiological parameters, the body weight was not
signiﬁcantly changed (420 ± 15, 438 ± 28, 407 ± 20g/b.w.,
resp., during phase A, B, and C). Daily food intake was
not diﬀerent in the three phases; the daily water intake was
increased in phase C with respect to both phases A and
B, but not signiﬁcantly. The urine volume produced was
also similar in the three phases. The daily fecal weight was
increased, but not signiﬁcantly in phase C: 7.5±0.5, 7.1±0.4
and 8.0 ± 0.2g/day, respectively, for phase A, B, and C. The
fecal content of water was reduced from phase A (49.7 ±
0.6%)tophaseB(46.7±0.5%).Afterthelaxativeassumption,
the water content of feces increased to 48.5 ±0.9%; (phase C
versus phase B; P<0.0001). Similarly, the water content of
the single fecal pellet was, respectively, 59.2 ± 0.8, 54.3 ± 0.8
and 58.0 ± 0.7% in the three phases (phase C versus phase
B; P<0.0001). No case of diarrhoea was registered both in
study and control group.
3.2. Histology. We did not detect any signs of inﬂammation
or alteration of the colic mucosa in the animals sacriﬁced
at the diﬀerent study time points, neither in the colic vein
ligation group nor in the control group. However a mild
mucosal edema was noticed in the animals sacriﬁced after
ligation of the colic vein (Figure 3). The average number of
PAS-positivecellsdetectedinthecryptsofcolicepitheliumof
studygrouprats,wasrespectively, 177±2 inphaseA,144±2
in phase B and 211 ± 2 cells/hpf in phase C (phase C versus
phase B: P<0.001).
In the control group, no diﬀerence was found in the
histological parameters, and the average number of PAS
positive cell was not signiﬁcantly diﬀerent in the three study
phases.
4. Discussion
Chronic constipation is an important worldwide issue which
aﬀects almost 25% of the western population [2]. The
general goal of all medical treatments for constipation is
to increase fecal water content by retention of intraluminal
water, increase of intestinal secretion, or shortening of
intestinal transit. However in some cases these treatments
are ineﬀective [1]. Once every medical therapeutical option
has failed, surgery can be proposed as a last remedy
to a selected and limited category of patients [5]. Slow
transit constipation, which is unresponsive to high doses of
laxatives, is considered the consequence of chronic intestinal
pseudoobstruction, a rare and severe neuropathic disorder
presenting with impaired gastrointestinal propulsion and
bowel obstruction, without any lesion occluding the gut
lumen. Patients suﬀering from this disease can view the
surgical approach as the last option to their condition; as
any surgical treatment, complication rate could be high [5].
Research for new therapeutical strategies addressing this
issue is therefore strongly encouraged.
The present investigation was prompted by the observa-
tion of bowel function normalization, following arterializa-
tion of the portal vein in a patient with acute liver failure,
who had previously complained of severe constipation. The
report of cases of portal hypertension due to a splenic
arteriovenous ﬁstula with symptoms of diarrhea [12, 13]
conﬁrmed us in the concept that intestinal congestion can
decrease water absorption in the colon and increase the
watery content of stools, thus improving the symptoms.
In this setting we focused on evaluating the eﬀect of
the surgically induced colic vein congestion on chronic4 Journal of Biomedicine and Biotechnology
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Figure 3: Histological images of the colic mucosa of study group animals sacriﬁced in the three diﬀerent phases.
constipation. We employed a model of pharmacological
constipation induced by loperamide (Sigma-Aldrich) [10]
which can resemble the chronic functional constipation,
presenting less daily fecal excretion, lower water content,
and thinner mucus of fecal pellets [14]. The gastrointestinal
functionality of the rats was observed in terms of quantity
and water content of fecal pellets at basal condition, after
loperamide injection and after surgical procedure. We did
not observe a diﬀerence in the amount of feces in the
three phases of the study. However, we did notice a trend
of increase in water content of fecal pellets in animals
treated with colic vein ligation compared to the basal and
constipation phases. The results were higher than in the
PEG 4,000 treatment control group, thus showing that colic
vein ligation has more potent laxative eﬀect in loperamide-
induced constipation than PEG 4,000. The osmotic force
for colonic ﬂuid excretion of PEG 4,000 has already been
documented [15], and the results obtained by the two
diﬀerent methods provide a sort of clinical validation of
the present surgical model, demonstrating the “laxative
like” eﬀect of the colic vein ligation. The control group,
however, did not represent a refractory constipation model,
and the colic vein ligation should be preferred over the
noninvasive pharmacological treatment limited to cases of
medical treatment failure. Loperamide has shown to reduce
the amount of mucus secreted by colic mucosa [10]; in
the present investigation, we have demonstrated that the
colic vein ligation can increase the amount of mucus in
the colic mucosa and reverse the loperamide eﬀect. We
observed a statistically signiﬁcant increase in PAS positive
cells, containing mucus, in the groups of animals after
colic vein ligation compared to the basal and constipated
groups, suggesting that this surgical technique produces a
laxative eﬀect and alleviates the symptoms of loperamide-
induced constipation. Since loperamide inhibits intestinal
water secretion, as seen in human jejunum [16], it is
possible that this mechanism should be compensated by the
inhibition of water reabsorption in the colon, induced by the
colic vein ligature with a resultant net ﬂuid increase in the
lumen.
T h ed e s c r i b e dp r o c e d u r ei nr a t sw i t hp h a r m a c o l o g i c a l l y
induced constipation showed to be easy and reproducible
without negative apparent side eﬀects or histologically
detectable damages. These positive results prompt the
development of additional experimental studies to better
characterize the physiopathological mechanism beneath the
observed improvement of constipation and to conﬁrm the
eﬃcacyandsafetyofthissurgicalmodelinthelongtermand
in large size animals, as swines. This step, which is crucial
for the clinical translation of this research, would allow a
better understanding of the eﬀect of this procedure on a
gastrointestinal system more similar to the human one. Once
assessed and veriﬁed the eﬃcacy of this therapy on other
preclinical animal models, a laparoscopic approach could be
applied as well, allowing to perform the procedure through
minimally invasive surgery.
5. Conclusions
The present paper reports a tentative of surgical approach to
constipation by colic vein ligation. The described procedure
in rats with pharmacologically induced constipation showed
to be eﬀective, easy, and reproducible without negative
apparent side eﬀects or histologically detectable damages.
These positive results prompt the development of additional
experimental studies to better characterize the physiopatho-
logical mechanism beneath the observed improvement of
constipation and to conﬁrm the eﬃcacy and safety of this
surgical model in the long term and in large size animals.
If these studies will conﬁrm and fortify our preliminary
results, the surgical procedure described could be considered
as a valid option for selected categories of patients suﬀering
from chronic constipation refractory to medical therapy. To
this end, it is critically important that translational medical
research bridges the gap between ﬁndings in basic science
and data in the clinical setting.
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